StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CNO.V$0.26+4.00%
Fair $0.26+0.0%

CNO.V

California Nanotechnologies Corp.

Basic Materials / Specialty ChemicalsTSXV

$0.26

+0.01 (+4.00%)

Fairly Valued+0.0%Fair Value $0.26Fund rank 29/100 · Data gapFallback financials|
SA 30/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $537280.00 · quality 48.3/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 50/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

30/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -6.8%, below the 5% threshold
Thesis & Journal · CNO.VLocal privado en este navegador · California Nanotechnologies Corp.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$12M

P/E

N/A

•

EV/EBITDA

18.3x

↑

ROE

-6.8%

↓

Gross Margin

73.8%

↑

Debt/Equity

0.70

↑
52-Week Range$0
$0$1

TradingView lightweight chart

CNO.V price, volumen y niveles de valoración

Último $0.260Periodo -40.9%
Fair value: $0.260

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+79.2%

FCF CAGR

+80.3%

FCF margin

12.8%

FCF / Net income

-5.03x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.2M · net income $-158333.0 · FCF $796998.0

2022-FY → 2025-FY

Gross margin

73.8%+3.7% pts

Operating margin

22.2%+2.5% pts

Net margin

-2.5%-21.1% pts

FCF margin

12.8%+0.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$6.2M$6.2M$3.3M$1.4M$1.1M
Net Income$-158333.00$-158333.00$381678.00$79764.00$200600.00
EBITDA$780966.00$780966.00$633342.00$337912.00$404992.00
EPS——0.010.000.01
Gross Margin73.8%73.8%70.0%72.2%70.0%
Operating Margin22.2%22.2%19.4%14.5%19.7%
Net Margin-2.5%-2.5%11.4%5.8%18.5%
Balance Sheet
Debt/Equity0.700.708.27-1.50-1.58
Current Ratio1.011.01———
Cash Flow
Free Cash Flow$796998.00$796998.00$89982.00$537280.00$136020.00
Returns
ROE-6.8%-6.8%261.5%-8.4%-18.7%
Valuation
P/E——37.0053.419.00
EV/EBITDA18.3018.3023.1516.1911.19
P/B5.705.7097.94——
Growth & Yield
Revenue Growth86.5%86.5%141.5%27.8%—
EPS Growth——310.8%-75.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -54.4%

Total return

-54.4%

Start / end P/E

n/dx → n/dx

EPS bridge

0.01 → n/d

Residual

-54.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-54.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.